Repigmentation of gray hair after thyroid hormone treatment;Repigmentación del pelo canoso tras tratamiento con hormona tiroidea

Actas Dermo-Sifiliograficas

Volumn 98, Issue 9, 2007, Pages 603-610

  Redondo, Pedro ^a   Guzman M ^a   Marquina, M ^a   Pretel, M ^a   Aguado, L ^a   Lloret, P ^a   Gorrochategui, A ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Clínica Dermatológica   (Spain)

Author keywords

Hair follicle; Melanocytes; Mice; Thyroid hormone

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LEVOTHYROXINE; LIOTHYRONINE; PREDNISONE; PSORALEN; THYROID HORMONE; VINCRISTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HAIR COLOR; HAIR FOLLICLE; HAIR GROWTH; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; MALE; MOUSE; MULTIPLE CYCLE TREATMENT; MYCOSIS FUNGOIDES; MYXEDEMA; NONHODGKIN LYMPHOMA; NONHUMAN; PUVA; SIDE EFFECT; SKIN PIGMENTATION;

EID: 37249005243     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70145-X     Document Type: Article

References (47)

1. Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29-54.
2. Rosen CJ, Holick MF, Millard PS. Premature graying of hair is a risk marker for osteopenia. Clin Endocrinol Metab. 1994;79:854-7.
3. Lerner AB. Gray hair and sympathectomy. Report of a case. Arch Dermatol. 1966;93:235-6.
4. Ortonne JP, Thivolet J, Guillet R. Graying of hair with age and sympathectomy. Arch Dermatol. 1982;118:876-7.
5. Tobin DJ, Bystryn JC. Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res. 1996;9:304-10.
6. Botchkareva NV, Botchkarev VA, Gilchrest BA. Fate of melanocytes during development of the hair follicle pigmentary unit. JID Symp Proc. 2003;8:76-9.
7. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341:491-7.
8. Tobin DJ, Hagen E, Botchkarev VA, Paus R. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)? J Invest Dermatol. 1998;111:941-7.
9. Botchkareva NV, Khlgatian M, Longley BJ, Botchkarev VA, Gilchrest BA. SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J. 2001;15:645-58.
10. Müller-Röver S, Handjiski B, van der Veen C, Eichmüller S, Foitzik K, McKay IA, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001; 117:3-15.
11. Staughton RCD. Neoplasms of the scalp. En: Staughton RCD, editor. The color atlas of hair and scalp disorders. Ipswich: Cowell Ltd; 1988. p. 59.
12. Robinson A, Jones W. Changes in scalp hair after cancer chemotherapy. Eur J Cancer Clin Oncol. 1989;25:155-6.
13. Philpott MP, Green MR, Kealey T. Human hair growth in vitro. J Cell Sci. 1990;97:463-71.
14. Takada K, Sugiyama K, Yamamoto I, Oba K, Takeuchi T. Presence of amelanotic melanocytes within the outer root sheath in senile white hair. J Invest Dermatol. 1992;99:629-33.
15. Verbov J. Erosive candidiasis of the scalp, followed by the reappearance of black hair after 40 years. Br J Dermatol. 1981;105:595-8.
16. Bean WB. A note on post inflammatory hair darkening. Arch Dermatol. 1959;79:681-3.
17. Pinkus H. Postinflammatory hair darkening. Arch Dermatol. 1960;82:155-6.
18. Sieve BF. Darkening of grey hair following para-amino benzoic acid. Science. 1941;94:257-302.
19. Read GM, Verapamil and hair colour change. Lancet. 1991;338:1520.
20. Hampson JP, Donnelly A, Lewis-Jones MS, Pye JK. Tamoxifen-induced hair colour change. Br J Dermatol. 1995;132:483-4.
21. Rebora A, Delmonte S, Parodi A. Cyclosporin A-induced hair darkening. Int J Dermatol. 1999;38:229-30.
22. Vesper JL, Fenske NA. Hair darkening and new growth associated with etretinate therapy. J Am Acad Dermatol. 1996;34:860.
23. Reynolds NJ, Crossley J, Ferguson I, Peachey RDG. Darkening of white hair in Parkinson's disease. Clin Exp Dermatol. 1989;14:317-8.
24. Wand M. Latanoprost and hyperpigmentation of eyeslashes. Arch Ophtalmol. 1997;115:1206-8.
25. Juhlin L, Ortonne JP. Red scalp hair turning dark brown at 50 years of age. Acta Derm Venereol (Stockh) 1986;66:71-3.
26. Hill LS. Reversal of premature hair greying in adult coeliac disease. Br Med J. 1980;281:115.
27. Shaffrali FCG, McDonagh AJG, Messenger AG. Hair darkening in porphyria cutanea tarda. Br J Dermatol. 2002;146:325-9.
28. Freinkel RK, Freinkel N. Hair growth and alopecia in hypothyroidism. Arch Dermatol. 1972;106:349-52.
29. Messenger AG. Thyroid hormone and hair growth. Br J Dermatol. 2000;142:631-5
30. Billoni N, Buan B, Gautier B, Gaillard O, Mahé Y, Bernard BA. Thyroid hormone receptor (beta) 1 is expressed in the human hair follicle. Br J Dermatol. 2000;142:645-52.
31. Thompson CC, Bottcher MC. The product of a thyroid hormone responsive gene interacts with thyroid hormone receptors. Proc Natl Acad Sci USA. 1997;94:8527-32.
32. Ahsan MK, Urano Y, Kato S, Oura H, Arase S. Immunohistochemical localization of thyroid hormone nuclear receptors in human hair follicles and in vitro effect of L-triiodothyronine on cultured cells of hair follicles and skin. J Med Invest. 1998;44:179-84.
33. Safer JD, Fraser LM, Ray S, Holick MF. Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid. 2001;11:717-24.
34. Safer JD, Crawford TM, Fraser LM, Hoa M, Ray S, Chen TC, et al. Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration. Thyroid. 2003;13:159-65.
35. Credille KM, Slater MR, Moriello KA, Nachreiner RF, Tucker KA, Dunstan RW. The effects of thyroid hormones on the skin of beagle dogs. J Vet Inter Med. 2001;15:539-46.
36. Soma T, Tsuji Y, Hibino T. Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle. J Invest Dermatol. 2002;118:993-7.
37. Kawakami T, Soma Y, Kawa Y, Ito M, Yamasaki E, Watabe H, et al. Transforming growth factor beta 1 regulates melanocyte proliferation and differentiation in mouse neural crest cells via stem cell factor/KIT signaling. J Invest Dermatol. 2002;118:471-8.
38. Burger P, Lukey PT, Coetzee S, Wilson EL. Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells. J Cell Physiol. 2002;190:83-91.
39. Peters EMJ, Tobin DJ, Botchkareva N, Maurer M, Paus R. Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-kit expression. J Histochem Cytochem. 2002;50:751-66.
40. Tsuji Y, Denda S, Soma T, Raftery L, Momoi T, Hibino T. A potential suppressor of TGF-beta delays catagen progression in hair follicles. JID Symp Proc.2003;8:65-8.
41. Niepomniszcze H, Amad RH. Skin disorders and thyroid diseases. J Endocrinol Invest 2001;24:628-38.
42. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74:120-3.
43. Gharami K, Das S. Thyroid hormone-induced morphological differentiation and maturation of astrocytes are mediated through the beta-adrenergic receptor. J Neurochem. 2000;75:1962-9.
44. Hu DN, Woodward DF, McCormick SA. Influence of autonomic neurotransmitters on human uveal melanocytes in vitro. Exp Eye Res. 2000;71:217-24.
45. Schallreuter KU. Beta-adrenergic blocking drugs may exacerbate vitiligo. Br J Dermatol. 1995;132:168-9.
46. Ichimiya M. Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture. J Dermatol. 1999;26:502-6.
47. Horikawa T, Norris DA, Johnson TW, Zekman T, Dunscomb N, Bennion SD, et al. DOPA-negative melanocytes in the outer root sheat of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol. 1996;106: 28-35.